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Continuous generation and regeneration of all 
blood and immune cells over the lifespan of an 
organism is ensured by a limited number of he-
matopoietic stem cells (HSCs). The vast majority 
of HSCs reside in the BM, whereas a small 
fraction of functional HSCs can be found in 
the blood circulation, both in mice and humans 
(Goodman and Hodgson, 1962; Richman et al., 
1976; Dorie et al., 1979; Körbling et al., 1981). In 
early development, the ability of HSCs to mi-
grate and engraft niches is important at the stage 
when HSCs exit the fetal liver and populate 
the BM (Orkin and Zon, 2008). In adults, HSCs 
have been shown to move toward the site of in-
jury or inflammation and participate in tissue re-
pair (Lapid et al., 2012). The migrating ability of 
HSCs is routinely used in clinical transplantation 
and gene therapy protocols, which are applied 
in the treatment of an increasing number of he-
matopoietic and nonhematopoietic diseases. Thus 
far, it is unknown how individual HSC clones 
migrate and distribute among skeletal niches 
after transplantation and how this is affected 
by mobilization-inducing cytokines.
Our limited knowledge of HSC migration 
is primarily based on results from parabiotic ro-
dents sharing a common circulation (Warren 
et al., 1960; Dorie et al., 1979; Wright et al., 2001; 
Abkowitz et al., 2003). These studies suggest 
that egress of HSCs into blood is continuous. 
Migrating cells are capable of reengrafting the 
BM and further contributing to hematopoiesis 
(Wright et al., 2001). Based on approximate cal-
culations, it was claimed that 1–5% of all HSCs 
are circulating daily (Bhattacharya et al., 2009). 
If this claim was correct, HSC distribution 
within the same mouse or across parabiotic mice 
would approach equilibrium within a few months. 
However, direct measurements of chimerism in 
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Hematopoietic stem cells (HSCs) are able to migrate through the blood stream and engraft 
bone marrow (BM) niches. These features are key factors for successful stem cell transplan-
tations that are used in cancer patients and in gene therapy protocols. It is unknown to 
what extent transplanted HSCs distribute throughout different anatomical niches in the 
BM and whether this changes with age. Here we determine the degree of hematopoietic 
migration at a clonal level by transplanting individual young and aged mouse HSCs labeled 
with barcoded viral vector, followed by assessing the skeletal distribution of hundreds of 
HSC clones. We detected highly skewed representation of individual clones in different 
bones at least 11 mo after transplantation. Importantly, a single challenge with the clini-
cally relevant mobilizing agent granulocyte colony-stimulating factor (G-CSF) caused rapid 
redistribution of HSCs across the skeletal compartments. Old and young HSC clones showed 
a similar level of migratory behavior. Clonal make-up of blood of secondary recipients 
recapitulates the barcode composition of HSCs in the bone of origin. These data demon-
strate a previously unanticipated high skeletal disequilibrium of the clonal composition of 
HSC pool long-term after transplantation. Our findings have important implications for 
experimental and clinical and stem cell transplantation protocols.
© 2014 Verovskaya et al. This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
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Figure 1. Old and young HSCs are asymmetrically distributed among various skeletal niches and migrate at a similar rate. (A) Experimental 
setup. BM cells were isolated from young and aged donors, and LSK48150+ cells were separately purified by cell sorting and subsequently pooled. After 
transduction with a barcoded vector library, cells were transplanted into lethally irradiated animals. Recipient mice were sacrificed 6–11 mo after trans-
plant. BM cells were isolated from four skeletal locations, and LSK48150+ cells of young and old origin were single-cell sorted into cytokine-rich medium. 
Colonies expanded to 30,000 cells were harvested for barcode analysis. (B) Schematic representation of the four bone groups that were analyzed.  
Bones analyzed in the same group are shown in the same color. (C) Skeletal distribution of barcoded clones in young (left) and old (right) LSK48150+ 
cells in a single mouse, analyzed 6 mo after transplantation. Clones that are colored white are unique, i.e., were found only once. The asterisks identify 
clones with distributions that are significantly different from random (P < 0.05 based on Monte Carlo simulations). The number of barcoded colonies 
analyzed for every skeletal location is indicated above the column. Clones found in four or more colonies and further used for distribution analysis are 
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were mixed and transduced with a barcoded vector library and 
transplanted into irradiated hosts. To achieve a statistically suffi-
cient number of young and old clones, several spatially closely 
related bones were pooled (Fig. 1 B). Young and old stem cells 
were isolated from four distinct skeletal regions: (1) spine; 
(2) sternum and bones of fore limbs; (3) left femur, left tibia, and 
left half of pelvic bone; and (4) right counterparts of these 
bones (Fig. 1 B). Single GFP+ LSK48150+ cells from young 
and old origin were sorted from primary recipients and clon-
ally expanded in the presence of cytokines to confirm the high 
proliferative capacity of these cells and to generate enough cells 
for robust barcode analysis (Fig. 1 A).
Both old and young HSC clones demonstrate a highly skewed 
skeletal distribution for at least 11 mo after transplantation
Mice were sacrificed 6–11 mo after transplantation to assess the 
dynamics of the migration process. Six mice were analyzed 
6-mo after transplant, whereas additional groups of two mice 
each were analyzed 10 and 20 wk later (at 8.5 and 11 mo, 
respectively). Approximately 100 colonies per mouse (mean 
98 ± 35; ranging from 38 to 160) were obtained and barcodes 
successfully analyzed. Detailed results of such an analysis for 
one of the mice are shown in Fig. 1 C. The distribution of 
different barcoded clones was highly diverse: although some 
clones were detected in all four analyzed locations (e.g., bot-
tom [pink, #5] clone in panel on old cells), others were found 
only in one site. Such heterogeneity of spatial distribution was 
observed both for old and young HSC clones, and it was not 
related to the total number of clones found in an animal. The 
observed differences in clonal distribution were of two kinds. 
Some clones were present in some bones and absent in others. 
Other clones were present in all observed bones, yet their sizes 
were very different. As differences in the occurrence of bar-
code frequencies might be purely random or related to differ-
ences in the total number of clones analyzed (i.e., minor error 
of measurement caused by a relatively small colony number), 
we tested whether the observed skewed distributions were sta-
tistically significant or rather happening by chance. To this end 
the dataset was tested against the null hypotheses of equal skel-
etal distribution of HSCs. Only relatively abundant clones rep-
resented by at least four colonies were taken for analysis (smaller 
clones per definition cannot be found in four locations). The 
data for all mice sacrificed 6 mo after transplantation are sum-
marized in Fig. 1 D (clones derived from young HSCs) and 
Fig. 1 E (clones derived from old HSCs). For individual clones, 
the contribution to the local stem cell compartment size at 
different locations could vary as much as from 8 to 83% or 
parabiotic mice demonstrated relatively slow rates of equili-
bration (Wright et al., 2001). Although this rate was dramatically 
increased upon administration of G-CSF, it did not result in 
full equilibration of HSCs between parabiotic mice (Abkowitz 
et al., 2003).
G-CSF–induced mobilization is routinely used in clinical 
BM transplantation and gene therapy protocols, allowing har-
vest of the HSC-enriched fraction from the donors’ blood 
(To et al., 1997). Stem cell mobilization in patients has been 
claimed to decline with age (Morris et al., 2003; Pozotrigo et al., 
2013); however, experimental data underlying this phe-
nomenon are limited and contradictory. Although multiple 
studies found a homing defect of old mouse HSCs (Liang 
et al., 2005; Dykstra et al., 2011), another study suggested that 
G-CSF–induced mobilization in aged mice was more effi-
cient than in young (Xing et al., 2006).
In this study, we analyzed posttransplantation skeletal lo-
calization of hundreds of young and old hematopoietic clones. 
To track individual stem cell clones, we labeled highly puri-
fied HSCs with a viral barcode label before transplantation 
(Gerrits et al., 2010; Verovskaya et al., 2013). We questioned 
whether old and young HSCs would respond differently to 
mobilizing stimuli. Our data demonstrate that migration of 
clones under steady-state conditions is very limited, such that 
clonal distribution does not reach equilibrium up to 11 mo 
after transplantation. However, migration was strongly acti-
vated and led to complete clonal equilibration upon a single 
mobilizing challenge. Clonal differences in HSC composition 
of specific skeletal sites were inherited upon secondary trans-
plantations from those particular bones and also resulted in 
different functional activity in secondary recipients.
RESULTS
Quantification of HSC migration by clonal analysis  
of distinct skeletal locations
Experiments with parabiotic animals demonstrated quite a 
slow exchange of HSC pools during an observation time up to 
22 wk (Wright et al., 2001; Abkowitz et al., 2003). Other au-
thors, however, claimed a continuously high level of HSC mi-
gration (Bhattacharya et al., 2009). Based on these observations, 
one would predict the clonal composition of the HSC com-
partment in all skeletal sites to equilibrate within a few months 
after transplantation. To address the extent of skeletal distribu-
tion of old and young HSC clones, we compared the barcode 
composition in four skeletal sites in recipients of barcoded BM 
cells (Fig. 1, A and B). Purified young (4 mo) and aged (24 mo) 
lineage Sca1+ c-Kit+ CD48 CD150+ (LSK48150+) cells 
cohorts of mice). X axis shows the rank of clone size, based on mean value over all four locations, ranked from most frequent to the least frequent. Y axis 
shows the contribution of a certain clone to the total pool in one location. Dots on the same vertical line reflect the size of a particular clone in each of 
the four different locations. The mean contribution for a given clone is shown with a horizontal line. As in C, clones significantly deviating from equal 
distribution (P < 0.05 based on Monte Carlo simulations) are marked with an asterisk. For clarity, four numbered clones from C are colored according to 
the bone group colors as in B. (E) Same as D, but shown for old clones (summary of two independent cohorts of mice; n = 6). (F) Same as D, but for young 
clones from mice sacrificed 8.5–11 mo after transplantation (one cohort; n = 4). (G) Same as F, but for old clones (n = 4). (H) Summary of the RSDs for all 
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Figure 2. G-CSF–induced mobilization leads to homogenization of skeletal HSC distribution of both young and old clones. (A) Experimental 
setup. Recipient mice were transplanted with young or old transduced LSK48150+ cells. The groups of mice were challenged by G-CSF 7 (young mice) or 
8 mo (old mice) after transplantation. 10–18 wk after treatment, all mice (both treated and untreated groups) were sacrificed. Clonal composition of dif-
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and 15 of 31 clones were significantly skewed across bone sites. 
Strikingly, a single G-CSF challenge led to complete random-
ization of HSC clones across the four studied locations (Fig. 2, 
C and E). Skewing completely disappeared in this group 
(Fig. 2 E). This indicates that HSC clones are readily mobilized 
and reenter the niches after mobilization. Colony-forming ef-
ficiency of LSK48150+ cells in treated and untreated animals 
was similar. We have also been able to retrieve up to three bar-
coded LSK48150+ colonies in spleen per mouse. The clones 
present in spleen are marked with a hashtag in Fig. 2.
It has been reported that the mobilization potential of 
HSCs might be affected by the age of the patient. For instance, 
older myeloma patients have been shown to be poorer mobi-
lizers compared with young counterparts (Morris et al., 2003; 
Pozotrigo et al., 2013). However, mobilization in old mice 
was shown to be more efficient than in young individuals 
(Xing et al., 2006). We addressed this controversy at the clonal 
level: we studied the extent of skeletal allocation of old bar-
coded HSC clones (24 mo at time of transduction and trans-
plantation; Fig. 2, G and H). Transplantations were performed 
as for recipients of young cells, and G-CSF was administered 
to half of the animals 8 mo after transplant. One of G-CSF–
treated mice suffered from a spleen rupture and died 1 wk after 
injection. The two remaining mice were sacrificed 10 wk after 
mobilization. The response was similar to young clones (Fig. 2, 
F and I), with the exception of 1 out of 13 clones (clone 2; 
Fig. 2 H). Although most of the clones equilibrated after 
G-CSF challenge, clone 2 was dominant in spine (11 of 35 colo-
nies carried this barcode). Although all young clones seem to be 
equally prone to mobilization, within the old cell population we 
cannot exclude the presence of both good and bad mobilizers.
To test this in a more direct manner, we studied clonal rep-
resentation of the LSK48150+ cells in BM and spleen at the 
peak of mobilization (1 wk after G-CSF administration). Recip-
ients of cotransplanted young and old cells (as shown at Fig. 1 A) 
were used to study the response within the same animal. The 
animals were mobilized 8.5 or 11 mo after transplantation, 
and LSK48150+ clones were harvested from BM and spleen 
(Fig. 2 J). The clonal composition of young LSK48150+ cells 
in BM and spleen was very similar (r = 0.62, P = 0.032; and 
r = 0.91, P < 0.001 for mouse 1 and 2, respectively; Fig. 2 J). Data 
for aged cells are not shown because of low cell chimerism.
0 to 79% (Fig. 1, D and E). It appeared that 8 out of 42 clones 
were significantly deviating from the expected mean (P < 
0.05, marked with asterisks). To test whether skeletal distribu-
tion was equalized in time, four additional mice were analyzed 
10 and 20 wk later (Fig. 1, F and G). Similarly to clones ana-
lyzed 6 mo after transplantation, we detected skewed clonal 
representation among the four skeletal sites. For 3 of 17 clones, 
this skewing was statistically significant, confirming that local 
dominance of HSC clones in certain skeletal regions is retained 
for at least 11 mo after transplantation.
Because previous studies demonstrated a decreased homing 
or binding to stroma of old HSCs (Liang et al., 2005; Xing 
et al., 2006; Dykstra et al., 2011), we questioned whether the 
extent of migration/spatial distribution of old HSCs across the 
skeleton was different from their young counterparts. To address 
this issue, we calculated the relative SD (RSD) for each of the 
clones found four or more times. The RSD allows us to compare 
variations in clones with different mean contributions. An 
RSD < 1 demonstrates low-level variance of distribution, whereas 
an RSD > 1 indicates high-level variance. Most young and 
old clones have RSD values >1, but the mean RSD for both age 
groups is very similar (Fig. 1 H), demonstrating once more that 
both populations have highly unequal skeletal distributions.
G-CSF–induced mobilization leads  
to redistribution of HSC clones
G-CSF administration mobilizes HSCs and progenitors into 
the circulation. G-CSF has also been shown to increase part-
ner chimerism when administered to a parabiotic animal 
(Abkowitz et al., 2003). To assess whether G-CSF affects clonal 
skeletal distribution, we analyzed a cohort of seven animals 
transplanted with young (4 mo old) barcoded LSK48150+ 
cells. As only one cell type was transplanted, it was possible to 
generate more in vitro colonies per clone and increase the ac-
curacy of the measurements. Three mice were mobilized 7 mo 
after transplantation, whereas four mice were left untreated. 
10–13 wk after G-CSF treatment, mice were sacrificed, and 
the barcode composition of the LSK48150+ pool was analyzed 
in different locations (Fig. 2 A). Additionally, LSK48150+ 
cells were sorted from the spleen. Similar to our results de-
scribed above, skeletal distribution of HSC clones in all four 
untreated animals was highly asymmetrical (Fig. 2, B and D), 
of old LSK48150+ cells relate to two cohorts (n = 4; one of the untreated animals originated from a separate cohort). (B) Example of clonal barcode 
representation in an untreated mouse transplanted with young cells. As in Fig. 1, identical colors relate to the same clone, and clones found only once are 
shown as white. (C) Same as B, but for a G-CSF–treated mouse. (D) Summary of skeletal clonal distributions in four recipient mice transplanted with 
young stem cells. The asterisks identify clones with distributions that are significantly different from random (P < 0.05 based on Monte Carlo simula-
tions). (E) Same as D, but for G-CSF–treated recipients (n = 3). (F) Summary of RSDs for all clones found in four or more colonies for the groups shown in 
D and E. The difference between the groups was tested by two-tailed Mann–Whitney test (***, P = 0.0004). (G) Analysis of clonal skeletal distribution in 
two recipient animals transplanted with old LSK48150+ cells. Statistical analysis was performed as in D and E. (H) Same as G for two G-CSF–treated 
recipients transplanted with old cells. (I) Summary of RSDs for all clones found in four or more colonies for the groups shown in G and H. The difference 
between the groups was assessed by two-tailed Mann–Whitney test (**, P = 0.0037). (D–I) Hashtags indicate the clones that were found in the spleen. 
Horizontal lines indicate mean contributions of a corresponding clone. (J) Comparison of clonal composition of LSK48150+ cells in BM and spleen/blood 
7 d after G-CSF treatment (n = 2). BM refers to pooled data from all four skeletal sites. Correlation between clone sizes in spleen and BM was significant 
for young cells in both mice (Pearson correlation, r = 0.62, P = 0.032; and r = 0.91, P < 0.001, respectively). Data for old cells are not shown because of 
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from stem cells that have exhausted long before analysis took 
place. Second, as only a fraction of bones was taken for analy-
sis, several clones (contributing to B and T cell production) 
could be missed in the analysis. As these factors are irrelevant 
in secondary transplantations, we compared barcodes in blood 
of 13 secondary recipients to the LSK48150+ pool composi-
tion in primary animals (Fig. 3 E). For all three populations 
(granulocytes and B and T cells), clonal distribution in blood 
was proportional to the corresponding LSK48150+ pool of the 
donor, and the slope was significantly different from zero (P < 
0.0001, P = 0.001, and P = 0.0001, respectively). Although 
in the primary animals only B cells and BM composition 
were significantly correlating, in secondary recipients clonal-
ity of both granulocytes and T cells significantly correlated with 
that of primitive cells originating from primary recipient (for 
granulocytes,  = 0.6704, P < 0.0001; for T cells,  = 0.3303, 
P = 0.0349). Note, however, that this is a mean regression for 
all clones. Individual data are scattered, and the degree of vari-
ation is substantial. It strongly argues against a simple relation 
between clone size in BM and blood. Obviously, there are 
other factors than clone size in the BM that affect clonal rep-
resentation in the blood.
Clonal composition of secondary transplant recipients 
depends on donor bone of origin and resembles  
the clonal composition of donor LSK48150+
As the clonal composition of the HSC pool differs in different 
skeletal locations, this could have ramifications on the inter-
pretation of BM biopsy composition or on the clonality of 
secondary recipients, resulting in an underestimated clonal rep-
resentation compared with the primary recipient. We tested 
whether the clonal composition of blood in secondary recipi-
ents, transplanted with BM from a single skeletal site, was simi-
lar to the HSC (LSK48150+) pool of the corresponding donor 
bone. As a negative control, we compared the data with those 
obtained from another skeletal site from the very same donor 
mouse. As some clones found in the LSK48150+ cell popula-
tion were not contributing to blood (Fig. 3), these could not be 
taken for similarity analysis using correlation estimates. There-
fore, we focused only on the barcodes found in blood at levels 
of >1% in either primary or secondary animals that correspond 
to the active stem cells and excluded barcodes that occurred 
less frequently. We further analyzed correlations and tested lin-
ear relationships between barcode make-up of the LSK48150+ 
pool in a certain skeletal site and matched (marked in green) 
or unmatched (marked in white) secondary recipients (Fig. 4). 
Despite large variation in the amount of output of mature 
blood cells per LSK48150+ clone (Fig. 3), both linearity 
and correlation were higher in the matched samples (Fig. 4 A, 
green). In 8 out of 12 cases of blood versus BM comparisons, 
barcode makeup of blood in secondary recipients was signifi-
cantly similar to the barcode composition of LSK48150+ cells 
in the donor bone of origin (P < 0.05). In contrast, correlations 
were insignificant in all unmatched samples. Similarly, we ob-
served good linearity between clone sizes in blood and HSCs 
in six groups (P < 0.05). Among unmatched groups, linear 
LSK48150+ cells represent the functional HSC population 
with highly variable developmental potential
In naive mice, the LSK48150+ phenotype allows us to purify 
a highly enriched HSC fraction (Kiel et al., 2005). However, 
ex vivo culture, transduction, and transplantation could in the-
ory affect the phenotype of primitive cells. To confirm that 
LSK48150+ colonies originated from functional HSCs, we 
compared barcode spectra in mature blood populations with 
those from single-cell expanded clones. Barcode fluctuations in 
blood samples were followed for a period of 10–11 mo in pri-
mary recipients and for an additional 6 mo in secondary re-
cipients (Fig. 3 A). Granulocytes and T and B lymphocytes 
were purified from blood of primary and secondary transplant 
recipients by FACS, and barcodes were analyzed by high-
throughput Solexa sequencing. Previously, we showed that 
clonal representation of the hematopoietic system becomes sta-
ble 3 mo after transplantation (Verovskaya et al., 2013); therefore, 
here we focused on maximum representation of a particular bar-
code in blood 12 wk and later after transplant. Results of such 
analysis for 4 primary recipients of young LSK48150+ cells 
and 13 secondary recipients are summarized in Fig. 3 B. We 
considered a barcode present if it was detected at a level of at 
least 0.5% in a relevant population (Verovskaya et al., 2013). Of 
70 barcodes detected in LSK48150+ cells, 43 were found in 
primary recipients, 17 of them were found in both primary and 
secondary recipients, and 10 of the remaining 27 barcodes were 
detected only in secondary animals. Surprisingly, the probability 
to detect a particular barcode in blood of primary recipients was 
not proportional to the corresponding clone size in LSK48150+ 
cells (Fig. 3 B). There seems to be no apparent relation between 
clone size of a particular stem cell and its repopulating activity 
measured in blood samples.
We decided to study this issue of clone size representation 
in more detail. For the barcodes found in both blood and HSCs 
(reflecting active stem cells), we next asked whether the fre-
quency of a barcode in LSK48150+ pool was correlated to 
frequencies in granulocytes and B and T lymphocytes. Fig. 3 C 
summarizes such analysis in primary recipients. It is apparent 
that the barcode representation data are quite disparate, and no 
obvious trend can be seen. To test whether the barcode repre-
sentation in blood and LSK48150+ colonies from BM showed 
a linear relationship, we calculated the relation between these 
two parameters by testing whether the slope of the regression 
line was significantly different from zero (Fig. 3 D). For granu-
locytes, the slope was significantly different from the null 
hypothesis (P = 0.0125). For T and B cells, the difference was 
insignificant, indicating no linear relationship between two 
variables (P = 0.2776 and P = 0.8, respectively). We also 
tested Spearman correlation between different cell subsets: 
only LSK48150+ and B cells significantly correlated, although 
the degree of correlation was low ( = 0.3725, P = 0.0275).
Several factors could contribute to the lack of linearity 
between barcode size in lymphocytes and LSK48150+. First, 
lymphocytes are long-lived blood cells that persist in the cir-
culation for months, in contrast to granulocytes that are re-
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Figure 3. Developmental potential of migrating HSC clones in primary and secondary recipients. (A) Experimental setup. Mature cells were puri-
fied from blood of primary and secondary transplant recipients by FACS, and barcodes were analyzed by high-throughput sequencing. Clonal composition 
in blood was compared with barcodes from expanded single stem cell–initiated colonies. (B) Barcode representation in primary LSK48150+ colonies and 
in three blood populations in primary or secondary recipients is plotted. The graph summarizes data from 70 clones found in 4 primary recipients of 
young cells and 13 secondary recipients transplanted with cells from 3 of these primary recipients. For one of the primary recipients (corresponding to 18 
barcodes), no secondary transplantations were performed. The colored legend identifies each of the four primary recipients from which the barcode data 
originate. Each row reflects a single clone/barcode and shows the maximum frequency with which that particular clone contributes to a particular lin-
eage, measured over a period of observation starting at 12 wk after transplantation. (C) Proportion of clones contributing to blood formation in primary 
and secondary recipients as a function of the clone size in the LSK48150+ pool. Note that overall 40% and 20% of the clones detected in BM 
LSK48150+ cells remains undetected in blood in primary or secondary recipients, respectively. (D) Correlation between barcode representation in BM 
LSK48150+ colonies and three mature blood populations in primary recipients (in one cohort of four mice). The best-fit line of linear regression analysis 
is shown (for granulocytes, slope [±CI95%] = 0.70 ± 0.26, P = 0.0125; for B cells, slope = 0.24 ± 0.21, P = 0.2776; and for T cells, slope = 0.07, P = 0.8). 
(E) Same as in D, but now in secondary recipients (13 mice). The slopes of the best-fit lines and p-values are as follows: for granulocytes, slope = 0.70 ± 
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used to quantitatively analyze HSC clone sizes in different 
bones and contributions of these clones to blood.
Our findings demonstrate that at very extended time inter-
vals (at least 11 mo) after transplantation, the distribution of 
both old and young HSC clones across multiple skeletal sites is 
highly skewed. This is in line with data showing relatively slow 
rates of HSC equilibration in parabiotic mice (Abkowitz et al., 
2003). However, our findings are in contrast with a study that 
suggested that 1–5% of HSC pool circulates daily (Bhattacharya 
et al., 2009). Simple dilution model simulation indicates that 
at such rates the clonal make-up of the HSC pool would equal-
ize within 4–6 mo (unpublished data). This prediction strongly 
contrasts our experimental observations. Notably, previous 
studies were never performed on the clonal HSC level, and 
therefore inequality in the level of egress of distinct HSC clones 
within one mouse was never addressed.
Strikingly, a single G-CSF mobilization regimen resulted 
in uniform spreading of HSC clones, which was preserved for 
many weeks after treatment. Here our data are quite distinct 
from results obtained in parabiotic models, in which only par-
tial equilibration of the HSC pool occurs (Abkowitz et al., 
2003). Our data confirm that mobilized HSCs retain the abil-
ity to reengraft BM niches. They also strongly suggest that all 
young HSCs are equally prone to mobilization; we did not 
find any evidence of mobilization of only a selected subset of 
stem cell clones.
Heterogeneity of the spatial clonal distribution of stem 
cells, as demonstrated here, is likely the combined result of 
multiple factors, such as the number, size, and migratory po-
tential of distinct HSCs. It has recently been shown that 
multiple (biologically and physically) separate niches may exist 
(Lo Celso and Scadden, 2011; Ding and Morrison, 2013; 
Greenbaum et al., 2013). One might speculate that certain 
HSCs home and expand in one but not another niche. Al-
though we have not addressed whether specific clones were 
found in specific niches, differential niche preference could 
potentially contribute to heterogeneity in the observed local-
ization patterns as well. This issue could potentially be resolved 
by further subfractionation of HSCs from increasingly more 
defined physical regions of the BM if it allows separation of 
different niches. It is recognized that G-CSF induces mobili-
zation through affecting specific ligand-receptor interactions 
and by inducing proteolytic cleavage of receptors (Lapid et al., 
2012). G-CSF affects not only HSCs, but also mature hema-
topoietic cells, as well as other cell types collectively referred 
to as the niche (osteoblasts, osteoclasts, and mesenchymal cells; 
Lapid et al., 2012). G-CSF treatment will inevitably cause 
modification of the niche. How this modification is contrib-
uting to the randomization of the clonal distribution is cur-
rently not known.
The fact that G-CSF efficiently equilibrates practically all 
clones indicates that each individually labeled HSC achieved 
sufficient clonal outgrowth to guarantee redistribution of its 
offspring across all bones tested. This observation also predicts 
that naturally occurring infections in mice, when endogenous 
G-CSF levels are elevated, will induce spatial equilibration of 
dependence was observed in one case (where the granulocytic 
population showed good fit to the bones of right hind leg, 
while originating from spine), further underscoring restricted 
interdependence between primitive and mature cells. This ex-
ample demonstrates that although Pearson correlation and lin-
ear regression both are testing linear relationship between two 
sets of data, the results might be different, and conclusions should 
be drawn with care.
DISCUSSION
Understanding the kinetics and molecular events underlying 
trafficking of HSCs is important both in basic hematology 
research and for implementation and interpretation of exper-
imental and clinical BM transplantation protocols. Here, we 
studied posttransplantation skeletal distribution of hundreds 
of HSC clones to address the extent of migration in steady-
state conditions and upon G-CSF–induced mobilization. 
Genetic barcoding of highly purified hematopoietic cells was 
Figure 4. Clonal blood composition in secondary recipients reflects 
the clonal HSC makeup of bone of origin. (A) Experimental setup. BM 
cells were isolated from two primary recipients (left and right hind legs 
from recipient 1 and spine and right hind leg from recipient 2) and were 
transplanted in four secondary recipients each. In parallel with secondary 
transplant, barcode frequencies were assessed in donor LSK48150+ cells. 
Granulocytes (G) and B and T cells were isolated from blood of secondary 
recipients 12–24 wk after transplant, and clonal analysis was performed 
by high-throughput sequencing. The relation between barcode represen-
tation in LSK48150+ colonies and blood of secondary transplant recipi-
ents was evaluated in matched (green) and unmatched (unmarked) 
samples. (B) The clonal composition of HSCs in the LSK48150+ pool in a 
certain skeletal site was compared with blood composition of related and 
unrelated secondary recipients using Spearman correlation and linear 
regression analysis. The tables summarize conditions in which correlation 
was significant and the slope was significantly different from zero. Sig-
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toward other niches. High cytokine levels, which are charac-
teristic of infections and are clinically widely used to induce 
stem cell mobilization, result in rapid and permanent homog-
enization of clonal stem cell distribution.
MATERIALS AND METHODS
Mice. C57BL/6 mice were purchased from Harlan, and C57BL/6.SJL and 
C57BL/6.SJLxC57BL/6 (all referred to as B6) mice were bred in the Central 
Animal Facility of the University Medical Center Groningen. C57BL/ 
6J-kitW-41J/kitW-41J (W41) mice were originally obtained from E. Dzierzak 
(Erasmus University Medical Center, Rotterdam, Netherlands) and were 
crossed with B6.SJL to obtain CD45.1 W41 as described previously (Dykstra 
et al., 2011). All experiments were approved by the University of Groningen 
Animal Experimentation Committee.
Purification and transduction of BM cells. LSK48150+ cell sorting and 
transduction were performed as described previously (Verovskaya et al., 2013). 
In brief, BM cells were isolated from bones of hind legs, spines, and sterna of 
naive B6 mice and stained with antibodies against Sca1, c-Kit, CD48, CD150, 
CD3, Gr1, CD11b, Ter119, and B220. LSK48150+ cells were sorted using 
MoFlo XDP and MoFlo Astrios (Beckman Coulter) cell sorters and prestimu-
lated in StemSpan medium (STEMCELL Technologies) supplemented with 
300 ng/ml stem cell factor (SCF), 1 ng/ml Flt3 ligand (both Amgen), and 
20 ng/ml IL-11 (R&D Systems) for 24 h. Cells were transduced with viral super-
natant containing barcoded MIEV vectors in RetroNectin-covered plates 
(Takara Bio Inc.) in the presence of 2 µg/ml polybrene (Sigma-Aldrich).
BM cell transplantation. 20–22 h after transduction, transduced cells were 
transplanted into lethally irradiated recipients (9–9.5 Gy) in the presence of 
1–2 million radioprotective cells from W41 or B6 origin. Efficiency of gene 
transfer, measured by flow cytometry (LSR-II; BD), was similar in all experi-
ments and ranged from 19 to 34% GFP+ cells. CD45 congenic B6 and W41 
strains were used to discriminate between donor and recipient cells and to 
distinguish young and aged cells in co-transplant setting. In the first young/
aged cohort, aged cells were CD45.2+, young cells were CD45.1+/CD45.2+, 
and recipients and donors of radioprotector cells were CD45.1+. In the sec-
ond cohort, aged cells were CD45.1+, young cells were CD45.2+, and recipi-
ents/radioprotector cells were CD45.1+/CD45.2+. Young donors were 4 mo 
old, aged donors were 24 mo old, and recipient animals were 2–6 mo old. For 
co-transplantations, young and aged cells were mixed in a 1:2 ratio before 
transduction and 20,500 cells were injected into the recipients. For young 
only cells, 10,000 cells were transplanted. For recipients of old HSCs, injected 
doses were 12,000 and 30,000 cells, respectively, in two cohorts. Transplanted 
transduced cells supported robust multilineage blood production. Donor and 
GFP chimerism were determined in blood 6 mo after transplantation as de-
scribed in Clonal analysis of blood samples. In old/young co-transplants 
(Figs. 1 and 2 J), old cells contributed 8.0 ± 7.3% of B cells (17.2 ± 13.2% 
GFP), 6.3 ± 5.1% of T cells (17.1 ± 14.1% GFP), and 15.7 ± 6.8% of granu-
locytes (22.7 ± 16.0% GFP), whereas young HSCs generated 81.2 ± 8.5% of 
granulocytes (14.3 ± 10.9% GFP), 75.4 ± 12.6% of T cells (9.7 ± 6.6% GFP), 
and 89.5 ± 8.8% of B cells (9.7 ± 4.2% GFP). In recipients of young cells 
(Fig. 2, B–F; and Fig. 3), donor HSCs produced 81.0 ± 8.2% of granulocytes 
(15.5 ± 8.2% GFP), 65.1 ± 11.8% of B cells (9.9 ± 4.8% GFP), and 61.2 ± 
8.0% of T cells (10.4 ± 4.7% GFP). In recipients of old HSCs (Fig. 2, G–I), 
these values were as follows: 87.8 ± 4.3% of granulocytes (23.1 ± 5.5% GFP), 
75.9 ± 10.4% of B cells (16.8 ± 10.7% GFP), and 60.9 ± 16.8% of T cells 
(14.1 ± 15.6% GFP). For secondary transplantations, 5–8 million whole BM 
cells were transplanted into lethally irradiated recipients.
G-CSF administration. To induce mobilization, we performed two injec-
tions of PEGylated G-CSF intraperitoneally (25 µg/mouse) with a 3-d inter-
val between treatments. In two mice sacrificed 1 wk after G-CSF administration, 
the efficiency of mobilization was confirmed by the presence of CFUs in the 
blood samples.
HSC clones. The physiological relevance of HSC redistribu-
tion remains unexplored.
Previous studies suggest differences in mobilization abilities 
of young and aged HSCs (Morris et al., 2003; Xing et al., 2006; 
Pozotrigo et al., 2013), but extrinsic and intrinsic effects could 
not be discriminated. Here, we observed similar migratory abili-
ties of young and old populations in co-transplantation settings, 
in transplants of only young or old cells, and upon mobilization, 
demonstrating that putative changes in mobilization with age 
must be primarily stem cell extrinsic, highlighting the possible 
role of niche ageing in modulating HSC mobilization.
Although barcode clonal analysis is potentially a powerful 
tool, several putative caveats must be considered. First, HSC 
activation during gene transfer procedures could affect their 
function. Although we (inevitably) did use ex vivo transduction 
and transplantation to follow HSCs, we demonstrate that these 
cells retain the ability for multilineage differentiation in irradi-
ated hosts. The extent of heterogeneity of repopulating ability 
and developmental capacity of individual HSCs observed is in 
agreement with experiments with transplantation of unmanip-
ulated single cells (Ema et al., 2005; Dykstra et al., 2007). There-
fore, we are confident that qualitatively our observations are 
not affected by the method, but rather seem to reflect the natu-
ral clonal behavior of repopulating HSCs. Second, we deter-
mined barcode identities only in single LSK48150+ cells that 
were able to form a colony in vitro. Although this approach al-
lowed us to confirm high proliferative activity of purified cells, 
bona fide stem cells that fail to produce a colony in our culture 
conditions would remain unnoticed. Alternatively, single-cell 
barcode analysis could be used; however, it is currently prob-
lematic because of the low success rate of PCR barcode ampli-
fication in a single cell. Third, this research was performed in 
irradiated recipients, and it remains a subject of investigation 
whether it affects HSCs migration.
Our findings have important implications for the design 
and interpretation of experimental and clinical transplanta-
tion protocols. First, we show that the current routine of using 
a single femur and tibia as a source for BM cells to initiate 
secondary transplants in mice results in an underestimation of 
the clonal repertoire and will exclude (potentially dominant) 
clones located elsewhere. This can contribute to a lack of 
consistency between the clonal make-up of BM and blood, 
and the use of cells obtained from multiple skeletal bones is 
advisable. Second, the same limitations apply for using BM 
biopsies to monitor clonal fluctuations in mice, cats, dogs, 
monkeys, or indeed in human gene therapy patients. Previous 
research on xenotransplantation of human cells into immuno-
deficient mice indicated that the clonal composition of BM 
in individual bones varied (Mazurier et al., 2003). However, 
the authors interpreted local clonal dominance as a sign of func-
tional differences between subsets of human HSCs, rather 
than reflecting general patterns of HSC distribution (Mazurier 
et al., 2003).
In conclusion, the data presented here demonstrate that 
upon transplant functional HSC clones preferentially expand 
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Suite (MOODS; Korhonen et al., 2009). Barcodes were sorted by read fre-
quencies in descending order, and barcode pairs varying by a single nucleotide 
were compared and lower frequency barcodes removed (removing barcodes 
with single-nucleotide substitution). Unique barcodes with frequencies under 
0.5% of total within the sample were removed (technical threshold). Samples 
with <1,000 reads were excluded from further analysis.
Statistical analysis. For testing the statistical significance of variations of 
clone size among different bone groups, experimental data series were com-
pared with expected random fluctuation around the mean. As the number of 
barcoded clones retrieved from different bones varied, we first normalized all 
clone frequencies to the bone location with the smallest number of success-
fully retrieved clones. A custom script in Python was used to test the proba-
bility of random deviation from mean (10,000 trials) for a given set of a data 
points (number of bone compartments), as well as total sequence reads (num-
ber of trials). The script allows us to simulate distribution of a certain number 
of reads (normalized number of reads related to a single clone) over several 
bone groups. Based on 10,000 trials, the script calculates probability of ob-
serving a deviation from the mean in a single bone. When the probability to 
detect the observed deviation was less than P < 0.05, this deviation was con-
sidered significant. This protocol allows us to identify all significantly deviat-
ing barcodes individually.
For correlation and linear regression analyses, coefficients of correlation 
(in the text r for Pearson, and  for Spearman) and p-values were derived using 
Prism (GraphPad Software). For linear regression analysis, when the slope devi-
ated from zero, this was used as an indicator of linear relationship between the 
populations. For comparing RSD values in G-CSF–treated and nontreated an-
imals, we used the nonparametric Mann–Whitney test, which allows compari-
son of not-normally distributed data. P-values were calculated using Prism.
Throughout this paper we mostly used correlation coefficients (Pearson 
and Spearman) as a measure of similarity between clonal composition of dif-
ferent samples. These functions are quantitative and therefore have particular 
limitations, especially in the case of poorly overlapping clone sets and sets with 
small numbers of barcodes. Nevertheless, they are well known and widely used, 
and when used properly provide sufficient statistical information.
We thank H. Moes, G. Mesander, and R.-J. van der Lei for expert cell sorting 
assistance; E. Wojtowicz for laboratory assistance; B. Dykstra, H. Schepers, and  
R. van Os for valuable discussions and suggestions; and P. van der Vlies and  
J. Bergsma for assistance with high-throughput sequencing.
This study was supported by the Netherlands Organization for Scientific 
Research (VICI grant to G. de Haan and TopTalent grant to E. Verovskaya), the 
National Roadmap for Large Scale Infrastructure (Mouse Clinic for Cancer and 
Aging), and the Netherlands Institute for Regenerative Medicine (NIRM).
The authors declare no competing financial interests.
Submitted: 29 August 2013
Accepted: 23 January 2014
REFERENCES
Abkowitz, J.L., A.E. Robinson, S. Kale, M.W. Long, and J. Chen. 2003. 
Mobilization of hematopoietic stem cells during homeostasis and after 
cytokine exposure. Blood. 102:1249–1253. http://dx.doi.org/10.1182/ 
blood-2003-01-0318
Bhattacharya, D., A. Czechowicz, A.G. Ooi, D.J. Rossi, D. Bryder, and 
I.L. Weissman. 2009. Niche recycling through division-independent 
egress of hematopoietic stem cells. J. Exp. Med. 206:2837–2850. http://
dx.doi.org/10.1084/jem.20090778
Ding, L., and S.J. Morrison. 2013. Haematopoietic stem cells and early lym-
phoid progenitors occupy distinct bone marrow niches. Nature. 495: 
231–235. http://dx.doi.org/10.1038/nature11885
Dorie, M.J., M.A. Maloney, and H.M. Patt. 1979. Turnover of circulating 
hematopoietic stem cells. Exp. Hematol. 7:483–489.
Dykstra, B., D. Kent, M. Bowie, L. McCaffrey, M. Hamilton, K. Lyons, 
S.J. Lee, R. Brinkman, and C. Eaves. 2007. Long-term propagation of 
Isolation of LSK48150+ from distinct skeletal locations after trans-
plantation. Transplant recipients were sacrificed by cervical dislocation 
under isoflurane anesthesia. Bones were isolated separately into four groups: 
(1) bones of fore limbs and sternum (front); (2) left femur, tibia, and left half 
of pelvic bone (left hind bones); (3) right femur, tibia, and right half of pelvic 
bone (right hind bones); and (4) bones of spine. After removal of muscle, cells 
were harvested by crushing bones in lysis solution (NH4Cl) and filtered 
through a 100-µm filter to remove debris. Nucleated cells were washed and 
stained with an antibody cocktail. Cells were washed and resuspended in a 
1-µg/ml solution of propidium iodide (PI). Antibodies were directed against 
Sca1, c-Kit, a panel of lineage markers (Ter119, CD11b, CD3, B220, and 
Gr1), CD48, and CD150 to discriminate different cell populations. CD45.1 
and/or CD45.2 staining was used to further distinguish donor and recipient 
cells. LSK CD48 cells from different locations were isolated in “enrich 
mode,” and donor-derived (young and/or old) LSK48150+ GFP+ cells were 
further single-cell sorted in round-bottom 96-well plates in cytokine-
supplemented medium to generate monoclonal cultures. Only 60 inner wells 
were used to minimize medium evaporation. Approximately 120 cells were 
sorted per bone group per mouse.
Monoclonal expansion of LSK48150+ cells. Colony growth was assessed 
by light microscopy at low (5×) magnification at several time points 10–35 d 
after sorting. Most large colonies formed within 2 wk of culture. Colonies 
reaching 30,000 cells or more (colony diameter reaching 60% of the diam-
eter of the viewing field) were used for barcode analysis. 45% of the sorted 
LSK48150+ cells formed large colonies and were harvested (this efficiency 
varied from 38 to 49% over four cohorts of mice used for analysis). The effi-
ciency of LSK48150+ cells to generate a large colony was not affected by 
G-CSF, 10–13 wk after its administration. It constituted 50% and 52% for un-
treated and G-CSF groups, respectively, in the cohort transplanted with young 
LSK48150+ cells and 52% and 44% correspondingly for untreated and treated 
recipients of old HSCs. In two mice sacrificed at the peak of mobilization, 14% 
of sorted cells were capable of forming a large colony. In some cases, young/old 
origin of the clones was established after expansion by PCR and restriction 
analysis for CD45 polymorphisms (Ramos et al., 2003).
Clonal analysis of LSK48150+ colonies. Genomic DNA was extracted 
and barcoded DNA was amplified with primers against internal vector se-
quence (Gerrits et al., 2010). Sanger sequencing was used to detect barcodes 
present in the samples. When less than five colonies could be retrieved from 
a BM sample, data were excluded from analysis.
Clonal analysis of spleen samples. Spleens were excised, weighed, and 
pressed through a 100-µm filter to generate single-cell suspensions. Red 
blood cells were lysed in NH4Cl solution, and cell suspensions were stained 
with an antibody cocktail as described in Isolation of LSK48150+ from dis-
tinct skeletal locations after transplantation. Splenic LSK48150+ GFP+ cells 
were individually sorted to generate monoclonal cultures as described in 
Monoclonal expansion of LSK48150+ cells.
Clonal analysis of blood samples. Clonal analysis in blood was performed 
by next-generation deep sequencing, as previously described (Verovskaya et al., 
2013). In brief, blood samples were collected every 6 wk for at least 6 mo and 
at the moment of sacrifice. Erythrocytes were lysed in NH4Cl buffer, and cells 
were stained with fluorophore-conjugated antibodies against Gr1, B220, CD3, 
CD45.1, and CD45.2, washed, and resuspended in PI solution. Mature blood 
populations were purified by FACS. Viable (PI) granulocytes (Gr1+ side scat-
ter high), T cells (CD3+), and B cells (B220+) of donor origin (CD45.1+) were 
sorted. Barcode sequence was amplified with tagged primers to allow multi-
plex analysis, pooled, and analyzed on an Illumina HiSeq 2000 platform. Data 
extraction was performed using in-house developed scripts in Python, Perl, 
Bioconductor, R, and VBA, as previously described (Verovskaya et al., 2013). In 
short, high-quality reads were extracted and compressed into sets of unique se-
quences. Samples were retrieved on the basis of exactly matching the primer 










Published February 24, 2014
JEM Vol. 211, No. 3 
Article
497
distinct hematopoietic differentiation programs in vivo. Cell Stem Cell. 
1:218–229. http://dx.doi.org/10.1016/j.stem.2007.05.015
Dykstra, B., S. Olthof, J. Schreuder, M. Ritsema, and G. de Haan. 2011. 
Clonal analysis reveals multiple functional defects of aged murine hema-
topoietic stem cells. J. Exp. Med. 208:2691–2703. http://dx.doi.org/10 
.1084/jem.20111490
Ema, H., K. Sudo, J. Seita, A. Matsubara, Y. Morita, M. Osawa, K. Takatsu, S. 
Takaki, and H. Nakauchi. 2005. Quantification of self-renewal capacity 
in single hematopoietic stem cells from normal and Lnk-deficient mice. 
Dev. Cell. 8:907–914. http://dx.doi.org/10.1016/j.devcel.2005.03.019
Gerrits, A., B. Dykstra, O.J. Kalmykowa, K. Klauke, E. Verovskaya, M.J. 
Broekhuis, G. de Haan, and L.V. Bystrykh. 2010. Cellular barcoding 
tool for clonal analysis in the hematopoietic system. Blood. 115:2610–
2618. http://dx.doi.org/10.1182/blood-2009-06-229757
Goodman, J.W., and G.S. Hodgson. 1962. Evidence for stem cells in the 
peripheral blood of mice. Blood. 19:702–714.
Greenbaum, A., Y.M. Hsu, R.B. Day, L.G. Schuettpelz, M.J. Christopher, 
J.N. Borgerding, T. Nagasawa, and D.C. Link. 2013. CXCL12 in early 
mesenchymal progenitors is required for haematopoietic stem-cell main-
tenance. Nature. 495:227–230. http://dx.doi.org/10.1038/nature11926
Kiel, M.J., O.H. Yilmaz, T. Iwashita, O.H. Yilmaz, C. Terhorst, and S.J. 
Morrison. 2005. SLAM family receptors distinguish hematopoietic stem 
and progenitor cells and reveal endothelial niches for stem cells. Cell. 
121:1109–1121. http://dx.doi.org/10.1016/j.cell.2005.05.026
Körbling, M., P. Burke, H. Braine, G. Elfenbein, G. Santos, and H. Kaizer. 1981. 
Successful engraftment of blood derived normal hemopoietic stem cells 
in chronic myelogenous leukemia. Exp. Hematol. 9:684–690.
Korhonen, J., P. Martinmäki, C. Pizzi, P. Rastas, and E. Ukkonen. 2009. 
MOODS: Fast search for position weight matrix matches in DNA 
sequences. Bioinformatics. 25:3181–3182. http://dx.doi.org/10.1093/ 
bioinformatics/btp554
Lapid, K., C. Glait-Santar, S. Gur-Cohen, J. Canaani, O. Kollet, and T. Lapidot. 
2012. Egress and mobilization of hematopoietic stem and progenitor 
cells: A dynamic multi-facet process. StemBook, editor. The Stem Cell 
Research Community, StemBook, Cambridge, MA. http://www.stembook.
org/node/762 (accessed July 15, 2013).
Liang, Y., G. Van Zant, and S.J. Szilvassy. 2005. Effects of aging on the homing 
and engraftment of murine hematopoietic stem and progenitor cells. Blood. 
106:1479–1487. http://dx.doi.org/10.1182/blood-2004-11-4282
Lo Celso, C., and D.T. Scadden. 2011. The haematopoietic stem cell niche at a 
glance. J. Cell Sci. 124:3529–3535. http://dx.doi.org/10.1242/jcs.074112
Mazurier, F., M. Doedens, O.I. Gan, and J.E. Dick. 2003. Rapid myeloerythroid 
repopulation after intrafemoral transplantation of NOD-SCID mice re-
veals a new class of human stem cells. Nat. Med. 9:959–963. http://dx 
.doi.org/10.1038/nm886
Morris, C.L., E. Siegel, B. Barlogie, M. Cottler-Fox, P. Lin, A. Fassas, M. 
Zangari, E. Anaissie, and G. Tricot. 2003. Mobilization of CD34+ cells 
in elderly patients (≥70 years) with multiple myeloma: Influence of age, 
prior therapy, platelet count and mobilization regimen. Br. J. Haematol. 
120:413–423. http://dx.doi.org/10.1046/j.1365-2141.2003.04107.x
Orkin, S.H., and L.I. Zon. 2008. Hematopoiesis: An evolving paradigm for stem 
cell biology. Cell. 132:631–644. http://dx.doi.org/10.1016/j.cell.2008.01.025
Pozotrigo, M., N. Adel, H. Landau, A. Lesokhin, N. Lendvai, D.J. Chung, D. 
Chimento, E. Riedel, X. Chen, L. Reich, et al. 2013. Factors impacting 
stem cell mobilization failure rate and efficiency in multiple myeloma in 
the era of novel therapies: Experience at Memorial Sloan Kettering Cancer 
Center. Bone Marrow Transplant. 48:1033–1039. http://dx.doi.org/10 
.1038/bmt.2012.281
Ramos, C.A., Y. Zheng, I. Colombowala, and M.A. Goodell. 2003. Tracing 
the origin of non-hematopoietic cells using CD45 PCR restriction frag-
ment length polymorphisms. Biotechniques. 34:160–162.
Richman, C.M., R.S. Weiner, and R.A. Yankee. 1976. Increase in circulat-
ing stem cells following chemotherapy in man. Blood. 47:1031–1039.
To, L.B., D.N. Haylock, P.J. Simmons, and C.A. Juttner. 1997. The biol-
ogy and clinical uses of blood stem cells. Blood. 89:2233–2258.
Verovskaya, E., M.J. Broekhuis, E. Zwart, M. Ritsema, R. van Os, G. de Haan, and 
L.V. Bystrykh. 2013. Heterogeneity of young and aged murine hematopoi-
etic stem cells revealed by quantitative clonal analysis using cellular barcoding. 
Blood. 122:523–532. http://dx.doi.org/10.1182/blood-2013-01-481135
Warren, S., R.N. Chute, and E.M. Farrington. 1960. Protection of the he-
matopoietic system by parabiosis. Lab. Invest. 9:191–198.
Wright, D.E., A.J. Wagers, A.P. Gulati, F.L. Johnson, and I.L. Weissman. 2001. 
Physiological migration of hematopoietic stem and progenitor cells. 
Science. 294:1933–1936. http://dx.doi.org/10.1126/science.1064081
Xing, Z., M.A. Ryan, D. Daria, K.J. Nattamai, G. Van Zant, L. Wang, Y. Zheng, 
and H. Geiger. 2006. Increased hematopoietic stem cell mobilization 











Published February 24, 2014
